I'd like to know is anyone here is familiar with t
Post# of 15624
If posters who've claimed to have spoken to someone at the company, or at Mediq are correct, the safety trial was expanded and enrolled patients with skin diseases in addition to those originally enrolled who were healthy.
If someone knows how far they'll permit trials to be modified we might get a better picture of how far they could take this initial clinical trial.
I certainly don't know this to be the case, but is it possible that in the Israeli system a trial can be modified and expanded to the point where sufficient data exists to actually approve the drug in Israel, and perhaps any other country that accepts their methodology. I'm not saying this is the case, I simply don't know, but such a streamlined form of working with drugs would certainly make sense.
Gary